Volume 10, Number 11—November 2004
ICEID & ICWID 2004
International Conference on Women and Infectious Diseases (ICWID)
Rubella Elimination and Improving Health Care for Women
|Time||Country||Target group||Vaccine used||Coverage achieved (%)|
|1998–2001||English-speaking Caribbean 18 countries||2.16 million men/women 20–29 y||MR and MMR||Average 80c Range 64–97|
|1999||Chile||2.5 million women 10–29 y||R||98|
|2001||Costa Rica||1.6 million men/women 15–39 y||MR||98c|
|2001 2002||Brazil 13 states 11 states||27 million, women 12–39 yd||MR||95|
|2002||Honduras||3.3 million men 5–39 y women 5–49 y||MR||98 Men 95 Women 98|
|2004||El Salvador||2.8 million men/women 15–39 y||MR||99 Men 93 Women 99|
|2004||Ecuador||4.8 million men/women 16–39 y||MR||100 Men 100 Women 100|
aCRS, congenital rubella syndrome; R, rubella containing vaccine; MR, double viral vaccine, measles/rubella containing vaccine; MMR, triple viral
cMen/women vaccinated in equal proportions.
dSome states modified the age of the group based on the year of the vaccine introduction.